Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9353372

    Compositions and their uses directed to huntingtin

    Ionis Pharmaceuticals, Inc. · Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. EP 3024825

    IMIDAZOLECARBOXAMIDE UND IHRE VERWENDUNG ALS FAAH INHIBITOREN

    BIAL PORTELA & CA SA [PT] · Granted Wed Jun 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. WO 2016085391

    DÉRIVÉS DE BIS (SULFONAMIDE) ETLEUR UTILISATION COMME INHIBITEURS DE MPGES

    ACTURUM LIFE SCIENCE AB [SE] · Granted Thu Jun 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. WO 2016085392

    DÉRIVÉS DE BIS (SULFONAMIDE) ET LEUR UTILISATION COMME INHIBITEURS DE MPGES

    ACTURUM LIFE SCIENCE AB [SE] · Granted Thu Jun 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9358204

    Formulations of viloxazine

    Supernus Pharmaceuticals, Inc. · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9359447

    Anti-mesothelin chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9359313

    Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

    VTV THERAPEUTICS LLC · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9359290

    Treatment of cataplexy

    Jazz Pharmaceuticals International III Limited · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9358306

    Photosensitizing antibody-fluorophore conjugates

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9358285

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9357924

    Composition, method, system and kit for optical electrophysiology

    UNIVERSITY OF CONNECTICUT · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9358283

    Diatom-based vaccines

    The Regents of the University of California · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9358287

    Method of treating stress hyperglycemia with human antibodies to the glucagon receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9359285

    Androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9359196

    Antiproliferative compositions comprising curcumin analogs and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9358240

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9358249

    Use of Pateamine A for the treatment of age-related muscle wasting

    The Regents of the University of California · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9359309

    Synthesis of syrbactin proteasome inhibitors

    The Regents of the University of California · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9359360

    TLR agonists

    The Regents of the University of California · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9359418

    Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9359429

    Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof

    PROTEIN DESIGN LAB, LTD. · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9359437

    Antibodies comprising chimeric constant domains

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9360446

    Methods and systems for measuring and using the oxidation-reduction potential of a biological sample

    Aytu BioScience, Inc. · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9359410

    Virus like particle purification

    Takeda Vaccines, Inc. · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9359380

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9359598

    Mutant MT-SP1 proteases with altered substrate specificity or activity

    Catalyst Biosciences, Inc. · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. EP 3027208

    DIAGNOSE UND THERAPIE VON KREBS MIT KREBSSTAMMZELLEN

    BIONTECH AG [DE] · Granted Wed Jun 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jun 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 2016159901

    DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

    GANYMED PHARMACEUTICALS AG [DE] · Granted Thu Jun 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9365612

    Caspase inhibitors

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9365823

    Virus clearance of neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9365540

    Benzimidazole derivatives as MCH receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9364462

    Alpha-1-adrenergic receptor agonist therapy

    The Regents of the University of California · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9364438

    Process for producing solid particles

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9364443

    Compositions and methods for drug delivery

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9364430

    Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol

    Relmada Therapeutics, Inc. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9364501

    Chlorite in the treatment of neurodegenerative disease

    The Regents of the University of California · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9364406

    Open chained or fused 1,1′-alkylene-bis-uracil derivatives, useful in skin UV-protection

    Regents of the University of Minnesota · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9364535

    Methods and compositions for modulating lymphangiogenesis, e.g., to treat transplant rejection, in a subject

    The Regents of the University of California · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9364448

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9364540

    Inhalable medicament

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9364471

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9364505

    Therapeutic composition for treatment of glioblastoma

    Regents of the University of Minnesota · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9364521

    Human tissue kallikrein 1 glycosylation isoforms

    DiaMedica Inc. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9364563

    Methods and compositions for liposomal formulation of antigens and uses thereof

    The Regents of the University of California · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9365520

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9365545

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9365504

    Salts of kukoamine B, preparation method and use thereof

    THE FIRST AFFILIATED HOSPITAL, THIRD MILITARY UNIVERSITY, PLA · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9365581

    Deuterated amlexanox

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.